PubMed Health⌕ Search

Biomedical subjects

D S Wright

Publications and source records attributed to D S Wright.

44 records · Page 3Linked to original sources

Dysrhythmias in apparently healthy elderly subjects.

Using 24-hour ambulatory electrocardiographic (ECG) monitoring, the incidence of cardiac dysrhythmias was investigated in 50 apparently healthy elderly subjects aged over 60 years. There was a high incidence of both ventricular and supraventricular ectopic beats, supraventricular tachycardia and sinus arrest. First- and second-degree block were also noted. The incidence of dysrhythmias bore no obvious relationship to age over 60, sex, blood presssure, cigarette smoking, caffeine and theophylline ingestion or resting 12-lead ECG abnormalities.

Aged↗

Assessment of endocardial leads for permanent cardiac pacing.

Catheter tip dislocation is the main complication of permanent pacemaker implantation using the subclavian vein. In this study of 50 patients we compared the incidence of complications using two endocardial electrodes specially designed to prevent tip dislocation. One catheter had a helical endocardial electrode and the other had retractable nylon barbs. The helical electrode was superior in every respect and we recommend its use for pacing through the subclavian vein.

Catheters, Indwelling↗

A sensitive high-performance liquid chromatographic assay for the cholecystokinin-B antagonist, CI-988, in human and monkey plasma.

A sensitive and specific high-performance liquid chromatographic assay for the non-peptide cholecystokinin subtype B receptor antagonist, CI-988, in human and cynomolgus monkey plasma has been developed and validated. The method involves isolation of CI-988 and internal standard by batch robotic solid phase extraction with a C18 cartridge, liquid chromatographic separation on a C18 column and quantitation by fluorescence detection. The human plasma assay is linear from 0.25 to 500 ng/mL for a 1.00-mL plasma aliquot. Assay precision for CI-988 based on human plasma quality control samples was within +/- 7.2% relative standard deviation with an accuracy of +/- 5.6% relative error. The monkey plasma assay is linear from 1.00 to 250 ng/mL for a 0.500-mL plasma aliquot. Assay precision based on monkey plasma quality control samples was within +/- 11.0% relative standard deviation with an accuracy of +/- 2.6% relative error.

Animals↗

Bioanalytic considerations for pharmacokinetic and biopharmaceutic studies.

The correct evaluation of pharmacokinetic and biopharmaceutic data can only be achieved if accurate analytic data are obtained. The accuracy of analytic data depends on the criteria used to validate the method. Consequently, careful scrutiny of drug stability, assay sensitivity, selectivity, recovery, linearity, precision, and accuracy is necessary for the proper interpretation of data. The importance of method validation and its influence on pharmacokinetic and biopharmaceutic data evaluation and interpretation will be discussed.

Biopharmaceutics↗

Analytical methods for measuring uric acid in biological samples and food products.

During the last 7 decades, uric acid methodology has kept pace with the introduction of state-of-the-art technology (e.g., spectroscopy, electrochemistry, chromatography) or the discovery of unique chemical processes (e.g., redox, enzymatic). We envision this practice will continue in the future. There never will be a single analytical method applicable for biofluids or foodstuffs. Therefore, it is imperative that the analyst not only understand the advantages and disadvantages of a procedure, but also thoroughly understand its underlying chemical and technological principles. Since many procedures available for analysis of biofluids and foodstuffs rely on identical chemical or technological principles, this report shall review both sample types and the available spectroscopic, electroanalytical, and chromatographic methods.

Animals↗